| PH | pulmonary hypertension |
| PA | pulmonary artery |
| PAH | pulmonary arterial hypertension |
| PVR | pulmonary vascular resistance |
| RV | right ventricular |
| RHF | right-heart failure |
| RVH | right-ventricular hypertrophy |
| mPAP | mean pulmonary artery pressure |
| LVEDP | left-ventricular end-diastolic pressure |
| WU | Wood units |
| WHO | World Health Organization |
| COPD | chronic obstructive pulmonary disease |
| IPAH | idiopathic PAH |
| HPAH | heritable PAH |
| APAH | associated PAH |
| PASMCs | pulmonary arterial smooth muscle cells |
| PAECs | pulmonary arterial endothelial cells |
| PAADCs | pulmonary arterial adventitial cells |
| HDMs | histone demethylases |
| HDACs | histone deacetylases |
| Sirt1 | Sirtuin-1 |
| Sirt3 | Sirtuin-3 |
| Sirt4 | Sirtuin-4 |
| BRD4 | bromodomain-containing protein 4 |
| 5-HT | 5-hydroxytryptamine |
| ERAs | endothelin receptor antagonists |
| PCAs | prostacyclin analogues |
| PDE-Is | phosphodiesterase 5 inhibitors |
| sGCs | soluble guanylate cyclase stimulators |
| FDA | the US Food and Drug Administration |
| CCBs | calcium channel blockers |
| NO | nitric oxide |
| cGMP | cyclic guanosine monophosphate |
| sGC | soluble guanylyl cyclase |
| PDE5 | phosphodiesterase-5 |
| cGMP | cyclic guanosine monophosphate |
| GMP | guanosine monophosphate |
| PGI2 | prostacyclin |
| cAMP | cyclic adenosine monophosphate |
| PKA | protein kinase A, |
| SC | subcutaneous |
| IV | infusion |
| ECE | endothelin-converting enzyme |
| IP3 | inositol triphosphate |
| E2 | estradiol |
| DHEA-S | dehydroepiandrosterone sulfate |
| Treg | regulatory T cells |
| Erα | estrogen receptor alpha |
| Erβ | estrogen receptor beta |
| TFAM | mitochondrial transcription factors |
| NFAT | nuclear factor of activated T-cells |
| NLPR3FSP-1 | NLR (NOD like receptor) family pyrin domain-containing 3 fibroblast-specific protein 1 |
| CD31 | platelet endothelial cell adhesion molecule (PECAM-1) also known as cluster of differentiation 31 |
| CYP1B1 | cytochrome P450 family 1 subfamily B member 1 |
| ncRNAs | noncoding RNAs |
| lncRNAs | long noncoding RNAs |
| circRNAs | circular RNAs |
| CpG | cytosine-phosphate-guanine |
| DNMTs | DNA methyltransferases |
| MTase | methyltransferase |
| H3K3me3 | histone 3 lysine 4 trimethylation |
| H3K27me3 | histone 3 lysine 27 trimethylation |
| K4me3 | lysine 4 trimethylation |
| MeCP1 | methylated CpG-binding protein 1 |
| MeCP2 | Methylated CpG-binding protein 2 |
| MBDs | methyl-CpG-binding domain proteins |
| SOD2 | superoxide dismutase 2 |
| FHR | Fawn-hooded rats |
| HIF-1α | hypoxia-inducible factor |
| Kv1.5 | voltage-gated K+ channels |
| siRNA | small interfering RNA |
| BMPR2 | bone morphogenetic protein receptor 2 |
| TBX4 | T-box 4 |
| ACVRL1 | activin A receptor-like type 1 |
| ENG | endoglin |
| SMAD9 | small mothers against decapentaplegic homolog 9 |
| CAV1 | caveolin-1 |
| KCNK3 | potassium channel subfamily K member 3 |
| ATP13A3 | ATPase 13A3 |
| SOX17 | SRY-box 17 |
| AQP1 | aquaporin 1 |
| BMP9 (GDF2) | growth differentiation factor 2 |
| EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 |
| TGF-β | transforming growth factor beta |
| BMP/TGF | bone morphogenic protein/transforming growth factor |
| WES | whole genome sequencing |
| SPS | small-patella syndrome |
| HMTs | histone methyltransferases |
| JmjC | Jumonji C family |
| LSD | lysine-specific demethylases |
| FAD | flavin adenine dinucleotide |
| α-KG | α-ketoglutarate |
| CAM | cell adhesion molecules |
| ICAMs | intercellular adhesion molecules |
| VCAMs | vascular cell adhesion molecules |
| MRTF-A | myocardin-related transcription factor A |
| NF-κB | nuclear factor kappa B |
| ASH2 | small homeotic 2 |
| WDR5 | WD repeat domain 5 |
| EZH2 | enhancer of zeste homolog 2 |
| TAC | transverse aortic constriction |
| ROS | reactive oxygen species |
| SOD1 | superoxide dismutase type 1 |
| GSK-J4 | a KDM6B inhibitor |
| LSD1 | lysine-specific histone demethylase 1A |
| HATs | histone acetyltransferases |
| HDACs | histone deacetylases |
| BRDPs | bromodomain-containing proteins |
| eNOS | endothelial nitric oxide synthase |
| PPHN | persistent PH of the newborn |
| PAB | pulmonary artery banding |
| MCT | monocrotaline |
| TSA | trichostatin A |
| VPA | valproic acid |
| MEF2 | myocyte enhancer factor 2 |
| IGF-1/pAKT | insulin-like growth factor-1/phosphorylation of protein kinase B |
| RVSP | RV systolic pressure |
| CO | cardiac output |
| TPR | pulmonary vascular resistance |
| BRD | bromodomain |
| BET | bromodomain and extra-terminal domain |
| BCL2 | B-cell lymphoma 2 |
| FOXM1 | Forkhead Box M1 |
| NAD+ | nicotinamide adenine dinucleotide |
| FOXO1 | Forkhead box protein O1 |
| CR | calorie restriction |
| MnSOD | manganese superoxide dismutase |
| SOD2 | superoxide dismutase 2 |
| Cat | catalase |
| Sirt3KO | Sirtuin-3 knockout |
| PDK | pyruvate dehydrogenase kinase |
| PDH | pyruvate dehydrogenase complex |
| GDH | glutamate dehydrogenase |
| DCA | dichloroacetate |
| UCP2 | uncoupling protein 2 |
| PI3K/AKT | phosphoinositide 3-kinase/protein kinase B |
| Sphk1 | sphingosine kinase 1 |
| SP1 | specificity protein 1 |
| Pri-miRNAs | primary miRNAs |
| RISC | RNA-induced silencing complex |